EUVIMEDEUVIMED entdecken
Crossref

AB008. Final analysis from PECATI phase 2 trial: lenvatinib in combination with pembrolizumab in pretreated advanced B3-thymoma and thymic carcinoma

Jordi Remon, Paolo Bironzo, Nicolas Girard, Laurence Bigay-Game, Oscar Juan-Vidal, Javier de Castro, Noemí Reguart, Laurent Greillier, Sophie Cousin, Eric Dansin, Margarita Majem, Reyes Bernabé und 8 weitere

Mediastinum · 2026-10 · 10 · AB008-AB008

DOI: 10.21037/med-26-ab008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediastinum, 2026-10. Verfasst von Jordi Remon und 19 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Remon, J., Bironzo, P., Girard, N., Bigay-Game, L., Juan-Vidal, O., Castro, J. D., Reguart, N., Greillier, L., Cousin, S., Dansin, E., Majem, M., Bernabé, R., Martinez, J. M., Díaz, M., Meya, A., Alcalá-López, D., García-Sanz, A., Righi, L., Novello, S., & Besse, B. (2026). AB008. Final analysis from PECATI phase 2 trial: lenvatinib in combination with pembrolizumab in pretreated advanced B3-thymoma and thymic carcinoma. Mediastinum, 10, AB008-AB008. https://doi.org/10.21037/med-26-ab008

Vancouver

Remon J, Bironzo P, Girard N, Bigay-Game L, Juan-Vidal O, Castro JD, et al. AB008. Final analysis from PECATI phase 2 trial: lenvatinib in combination with pembrolizumab in pretreated advanced B3-thymoma and thymic carcinoma. Mediastinum. 2026;10:AB008-AB008. doi:10.21037/med-26-ab008

BibTeX
@article{Remon2026,
  author = {Remon, Jordi and Bironzo, Paolo and Girard, Nicolas and Bigay-Game, Laurence and Juan-Vidal, Oscar and Castro, Javier de and Reguart, Noemí and Greillier, Laurent and Cousin, Sophie and Dansin, Eric and Majem, Margarita and Bernabé, Reyes and Martinez, Joaquin Mosquera and Díaz, Marta and Meya, Alba and Alcalá-López, Daniel and García-Sanz, Alicia and Righi, Luisella and Novello, Silvia and Besse, Benjamin},
  title = {AB008. Final analysis from PECATI phase 2 trial: lenvatinib in combination with pembrolizumab in pretreated advanced B3-thymoma and thymic carcinoma},
  journal = {Mediastinum},
  year = {2026},
  volume = {10},
  pages = {AB008--AB008},
  doi = {10.21037/med-26-ab008}
}
Kostenlos starten →